IUPAC/Chemical Name
(S)-2-Methoxy-5,8,14,14a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquinolino[2,1-b]isoquinolin-1-ol
InChi Key
VSCSJMRNBGGEEP-AWEZNQCLSA-N
InChi Code
InChI=1S/C19H19NO4/c1-22-15-3-2-11-4-5-20-9-13-8-17-16(23-10-24-17)7-12(13)6-14(20)18(11)19(15)21/h2-3,7-8,14,21H,4-6,9-10H2,1H3/t14-/m0/s1
SMILES Code
OC1=C(OC)C=CC2=C1[C@@]3([H])N(CC2)CC4=CC(OCO5)=C5C=C4C3
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
325.36
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Horst B, Wanner MJ, Jorgensen SI, Hiemstra H, van Maarseveen JH. Total Synthesis of the Ortho-Hydroxylated Protoberberines (S)-Govaniadine, (S)-Caseamine and (S)-Clarkeanidine via a Solvent-directed Pictet-Spengler reaction. J Org Chem. 2018 Nov 19. doi: 10.1021/acs.joc.8b02378. [Epub ahead of print] PubMed PMID: 30451502; PubMed Central PMCID: PMC6328280.
2: Sivakumaran N, Samarakoon SR, Adhikari A, Ediriweera MK, Tennekoon KH, Malavige N, Thabrew I, Shrestha RLS. Cytotoxic and Apoptotic Effects of Govaniadine Isolated from Corydalis govaniana Wall. Roots on Human Breast Cancer (MCF-7) Cells. Biomed Res Int. 2018 Jul 24;2018:3171348. doi: 10.1155/2018/3171348. eCollection 2018. PubMed PMID: 30140694; PubMed Central PMCID: PMC6081593.
3: Marques LMM, Callejon DR, Pinto LG, de Campos ML, de Oliveira ARM, Vessecchi R, Adhikari A, Shrestha RLS, Peccinini RG, Lopes NP. Pharmacokinetic properties, in vitro metabolism and plasma protein binding of govaniadine an alkaloid isolated from Corydalis govaniana Wall. J Pharm Biomed Anal. 2016 Nov 30;131:464-472. doi: 10.1016/j.jpba.2016.09.003. Epub 2016 Sep 3. PubMed PMID: 27686399.
4: Muhammad N, Shrestha RL, Adhikari A, Wadood A, Khan H, Khan AZ, Maione F, Mascolo N, De Feo V. First evidence of the analgesic activity of govaniadine, an alkaloid isolated from Corydalis govaniana Wall. Nat Prod Res. 2015;29(5):430-7. doi: 10.1080/14786419.2014.951933. Epub 2014 Aug 26. PubMed PMID: 25154594.
